Search Ontology:
ChEBI
(S)-timolol (anhydrous)
- Term ID
- CHEBI:9599
- Synonyms
-
- (-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
- (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
- (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
- (S)-1-(1,1-(dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
- (S)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
- (S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol
- (S)-timolol
- 1-(tert-butylamino)-3-[4-(1,4-oxazinan-4-yl)-1,2,5-thiadiazol-3-yloxy]-(2S)-propan-2-ol
- S-(-)-3-(3-tert-butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
- Timolol
- Definition
- The (S)-(-) (more active) enantiomer of timolol. A beta-adrenergic antagonist, both the hemihydrate and the maleate salt are used in the mangement of glaucoma, hypertension, angina pectoris and myocardial infarction, and for the prevention of migraine.
- References
-
- Beilstein:1084707
- CAS:26839-75-8
- DrugBank:DB00373
- Drug_Central:4061
- KEGG:C07141
- KEGG:D08600
- LINCS:LSM-2176
- PDBeChem:TIM
- PMID:10891117
- PMID:11300874
- PMID:11728183
- PMID:11784135
- PMID:14971904
- PMID:15027870
- PMID:15857133
- PMID:1635066
- PMID:2002467
- PMID:2579237
- PMID:2872332
- PMID:2892933
- PMID:2903243
- PMID:6094812
- PMID:6109024
- PMID:6113285
- PMID:6126588
- PMID:6134834
- PMID:8568799
- PMID:9288160
- Patent:DE1925956
- Patent:DE2915955
- Patent:US3655663
- Patent:US3657237
- Reaxys:1084707
- Wikipedia:Timolol
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
- inverse has_part
-
- inverse is_conjugate_acid_of
-
- inverse is_enantiomer_of
-
- is_conjugate_base_of
-
- is_enantiomer_of
-
Phenotype
Phenotype resulting from (S)-timolol (anhydrous)
Phenotype where environments contain (S)-timolol (anhydrous)
Phenotype modified by environments containing (S)-timolol (anhydrous)
Human Disease Model